cmAngio® vs EchoGo Pro

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CureMetrix
VS
by Ultromics

AI Verdict

cmAngio® and EchoGo Pro both utilize AI in medical imaging to contribute to cardiovascular health assessment. However, cmAngio® focuses on detecting Breast Arterial Calcifications on mammograms for risk assessment, whereas EchoGo Pro automates stress echocardiography analysis to diagnose coronary artery disease. They address different aspects of cardiac health using distinct imaging modalities and diagnostic approaches.

Choose cmAngio® if…

Choose cmAngio® if your primary objective is to proactively assess cardiovascular risk in women by leveraging existing mammography data. This tool is ideal for identifying Breast Arterial Calcifications (BAC) without requiring additional radiation or procedures, integrating seamlessly into routine breast screening workflows to provide early insights into cardiovascular health.

View cmAngio® →

Choose EchoGo Pro if…

Choose EchoGo Pro if you aim to significantly enhance the efficiency and accuracy of stress echocardiography analysis for diagnosing coronary artery disease. This AI-powered cloud solution is best suited for cardiology departments seeking near-instant, automated reports to streamline diagnostic workflows and improve patient management for suspected CAD.

View EchoGo Pro →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature cmAngio® EchoGo Pro
Pricing Paid, out-of-pocket Contact vendor for pricing
Deployment Cloud-based, integrates with any DICOM-compliant viewer Cloud-based (SaaS)
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

EchoGo Pro

Both tools emphasize ease of integration and cloud-based accessibility. However, EchoGo Pro's SaaS model explicitly states it 'requires no software installation or extensive training', which offers a slightly clearer advantage in immediate usability compared to cmAngio's 'quick and easy installation (less than an hour)'.

Clinical Value

EchoGo Pro

Both are FDA-cleared and address significant clinical needs. EchoGo Pro directly states it 'improves diagnostic accuracy and reduces misdiagnosis' for coronary artery disease, offering a clear, quantifiable clinical outcome. While cmAngio aids in early risk assessment for cardiovascular health, the direct impact on diagnostic accuracy gives EchoGo Pro a slight edge.

Pricing & Value

EchoGo Pro

Both tools require direct contact for pricing details. However, EchoGo Pro provides information about available reimbursement codes for related EchoGo products (e.g., CPT 0932T, NTAP XXE2X19), which offers a clearer path to understanding potential financial viability and return on investment for healthcare providers, even if not directly for EchoGo Pro itself.

Enterprise Readiness

EchoGo Pro

Both are cloud-based, HIPAA-compliant, and FDA-cleared. EchoGo Pro explicitly states it 'has_baa: 1' and is a 'vendor-neutral system, compatible with any PACS' with 'seamless integration with existing clinical workflows (DICOM, HL7)'. CmAngio requires contacting the vendor for BAA details and, while compatible with DICOM viewers, doesn't explicitly mention vendor neutrality or HL7 integration in the same detail.

Innovation

Tie

Both tools demonstrate significant innovation by applying AI to medical imaging in novel ways. CmAngio repurposes mammography data for cardiovascular risk assessment, while EchoGo Pro automates and enhances stress echocardiography analysis for coronary artery disease diagnosis. Both represent substantial advancements in their respective fields.

Support & Docs

Tie

Neither the provided structured facts nor publicly available web searches offer specific details regarding the depth or accessibility of support and documentation for either cmAngio or EchoGo Pro. Both companies generally mention customer support and training on their websites.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature cmAngio® EchoGo Pro
Product Name cmAngiou00ae EchoGo Pro
Primary AI Function/Detection Target Detecting Breast Arterial Calcifications (BAC) on mammograms Automates stress echocardiography analysis to improve the diagnosis of coronary artery disease
AI Categories Cardiology AI, OB/GYN AI, Radiology & Imaging AI Cardiology AI, Radiology & Imaging AI
Medical Specialties Cardiology, Obstetrics & Gynecology, Radiology Cardiology
Key Feature: Output/Reporting Provides visualization of BAC location on a scorecard Provides near-instant, comprehensive reports
Key Feature: Integration/Compatibility Compatible with any DICOM-compliant viewer Vendor-neutral system, compatible with any PACS; Seamless integration with existing clinical workflows (DICOM, HL7)

Videos

Demos, reviews, and walkthroughs featuring cmAngio® and EchoGo Pro.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

cmAngiou00ae by CureMetrix is designed to detect Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. EchoGo Pro by Ultromics automates stress echocardiography analysis to improve the diagnosis of coronary artery disease (CAD).
cmAngiou00ae processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams. EchoGo Pro is an AI-powered cloud solution that automates stress echocardiography analysis.
cmAngiou00ae is compatible with any DICOM-compliant viewer and boasts quick and easy installation, typically in less than an hour. EchoGo Pro is a vendor-neutral, cloud-based (SaaS) system that integrates seamlessly with existing clinical workflows via DICOM and HL7, requiring no software installation or extensive training.
For EchoGo Pro, reimbursement codes are available for related EchoGo products, such as CPT 0932T for EchoGo Heart Failure in outpatient settings and NTAP XXE2X19 for inpatient settings. The provided information for cmAngiou00ae does not specify available reimbursement codes.
cmAngiou00ae provides visualization of BAC location on a scorecard, enabling BAC identification and reporting without additional radiation or procedures. EchoGo Pro delivers near-instant, comprehensive reports to improve diagnostic accuracy and reduce misdiagnosis of coronary artery disease.
cmAngiou00ae is relevant for Cardiology, Obstetrics & Gynecology, and Radiology specialties due to its focus on BAC detection on mammograms. EchoGo Pro is primarily designed for Cardiology, as it automates stress echocardiography analysis for coronary artery disease diagnosis.

Backers

Who funded each tool's parent company.

cmAngio®

AI Tool Finder
AI-powered search. Results may not be comprehensive.